Literature DB >> 27765694

Postoperative Outcome of Cystic Renal Cell Carcinoma Defined on Preoperative Imaging: A Retrospective Study.

Jung Jae Park1, Byong Chang Jeong2, Chan Kyo Kim3, Seong Il Seo2, Keumhee C Carriere4, Minji Kim5, Byung Kwan Park6, Seong Soo Jeon2, Hyun Moo Lee2, Han Yong Choi2.   

Abstract

PURPOSE: We evaluated the postoperative outcome of cystic renal cell carcinoma defined on preoperative computerized tomography. We also sought to find the optimal cutoff of the cystic proportion in association with patient prognosis.
MATERIAL AND METHODS: In this institutional review board approved study with waiver of informed consent, 1,315 patients were enrolled who underwent surgery for a single renal cell carcinoma with preoperative computerized tomography. The cystic proportion of renal cell carcinoma was determined on computerized tomography. The optimal cutoff of the cystic proportion was explored regarding cancer specific survival. Renal cell carcinomas were categorized as cystic or noncystic renal cell carcinoma according to a conventional cutoff (ie cystic proportion 75% or greater) and an optimal cutoff. Postoperative outcomes were then compared between the 2 groups. Multivariate Cox regression analysis was performed to determine the independent predictor of cancer specific survival.
RESULTS: Of the 1,315 lesions 107 (8.1%) were identified as cystic renal cell carcinoma according to a conventional cutoff. The postoperative outcome of cystic renal cell carcinoma was significantly better than that of noncystic renal cell carcinoma (p <0.001). Neither metastasis nor recurrence developed after surgery in patients with cystic renal cell carcinoma. In association with the cancer specific survival rate, the optimal cutoff of the cystic proportion was 45% and 197 cases (15.0%) were accordingly defined as cystic renal cell carcinoma. On Cox regression analysis, a cystic proportion of 45% or greater of the renal cell carcinoma was an independent predictor of a favorable outcome regarding cancer specific survival (HR 0.34, p = 0.03).
CONCLUSIONS: Cystic renal cell carcinoma defined on preoperative computerized tomography is associated with low metastatic potential and favorable outcomes after surgery. Particularly, a cystic proportion of 45% or greater is an independent prognostic factor for favorable survival.
Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  carcinoma; cysts; local; mortality; neoplasm metastasis; renal cell; tomography; x-ray computed

Mesh:

Year:  2016        PMID: 27765694     DOI: 10.1016/j.juro.2016.10.055

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging.

Authors:  Mahyar Kashan; Mazyar Ghanaat; Andreas M Hötker; Cihan Duzgol; Alejandro Sanchez; Renzo G DiNatale; Kyle A Blum; Maria F Becerra; Brandon J Manley; Jozefina Casuscelli; Michael Chiok; Jonathan A Coleman; Paul Russo; Satish K Tickoo; Oguz Akin; A Ari Hakimi
Journal:  J Urol       Date:  2018-03-01       Impact factor: 7.450

Review 2.  Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment.

Authors:  Stuart G Silverman; Ivan Pedrosa; James H Ellis; Nicole M Hindman; Nicola Schieda; Andrew D Smith; Erick M Remer; Atul B Shinagare; Nicole E Curci; Steven S Raman; Shane A Wells; Samuel D Kaffenberger; Zhen J Wang; Hersh Chandarana; Matthew S Davenport
Journal:  Radiology       Date:  2019-06-18       Impact factor: 11.105

Review 3.  Imaging and Screening of Kidney Cancer.

Authors:  Alberto Diaz de Leon; Ivan Pedrosa
Journal:  Radiol Clin North Am       Date:  2017-11       Impact factor: 2.303

4.  Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway.

Authors:  Ning Wang; Rongjiang Wang; Jianer Tang; Jianguo Gao; Zhihai Fang; Meng Zhang; Xufeng Shen; Lingqun Lu; Yu Chen
Journal:  Contrast Media Mol Imaging       Date:  2022-09-15       Impact factor: 3.009

Review 5.  Imaging Advances in the Management of Kidney Cancer.

Authors:  Katherine M Krajewski; Ivan Pedrosa
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.